Skip to main content

Stone Warren's Form 4 filing

Neogenomics IncNEO · filed May 13, 2025

Accession no.
0001077183-25-000104
Filed
May 13, 2025
Trade date
May 11-12, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $48.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Stone WarrenCIK 0001955295Officer (Pres & Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 11, 2025Common StockMOption exerciseAcquired+9,613$0.00F1$0104,921Direct
May 11, 2025Common StockFTax withholdingDisposed−2,341$0.00$0102,580Direct
May 12, 2025Common StockPPurchaseAcquired+5,700$8.58+$48,906108,280Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 11, 2025Common StockMOption exerciseDisposed−9,613$0.00$09,613Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)